Regeneron Pharmaceuticals said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between ...

Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...

Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s ...

The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. With its ...

A gene therapy from Regeneron Pharmaceuticals Inc. improved hearing in nearly all deaf children in a clinical trial, results ...

OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic ...

Hyderabad: Cell and gene therapy solutions provider Miltenyi Biotec on Monday announced the roll-out of what is touted as ...

Miltenyi Biotec opens cell & gene therapy centre in Genome Valley, advancing innovation in combating diseases like cancer.

Miltenyi Biotec opens cell and gene therapy center in Hyderabad, advancing medical research and innovation in Life Sciences.

Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...

A bone marrow transplant process co-developed by investigators at the Johns Hopkins Kimmel Cancer Center is safe and curative ...

Partnership aims to utilize real-world insights on more than 70,000 de-identified patients with retinitis pigmentosa to advance gene therapy treatmentsSAN FRANCISCO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ...